• S&P 500: 1,351.95
  • Change: 0.15%
$2.44 -0.01 (-0.41%)
2/9/2012 3:59 PM

ENTREMED, INC. (NASDAQ:ENMD)

CAPS Rating: 1 out of 5

A clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the blood vessels that nourish them.

Current Price $2.44 Mkt Cap $29.86M
Open $0.00 P/E Ratio 0.00
Prev. Close $2.45 Div. (Yield) N/A (N/A)
Daily Range $2.24 - $2.45 Volume 90,722
52-Wk Range $0.90 - $5.57 Avg. Daily Vol. 0

News & Discussion Boards

Caps

This ticker is not currently Ratable.

All Players

51 Outperform
16 Underperform
 

All-Star Players

8 Outperform
12 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top ENMD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

ShuntSD (96.37)
Submitted October 20, 2006

As others say, a gamble with huge upside. But the small molecule research is promising and acquisition was a nice move. Keep close eye on it with stops.

Add Comment | Reply | Report this Post

hlacheen (98.88)
Submitted December 22, 2006

Just look at the income statement and cash flow.... this company is a cash-burning disaster, it is NOT worth $120m

Add Comment | Reply | Report this Post
ENMD VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ENMD.

Recs

0
Member Avatar aquaregia67 (26.51) Submitted: 12/17/2010 11:54:55 PM : Outperform Start Price: $4.98 ENMD Score: -59.60

Potential drug progressing through phase 2 trials with multiple MOAs and the potential to act against a myriad of different cancers. Almost no side effects have been seen which is extremely rare for any anti-cancer drug, offering the further prospect it can be used as an adjuvant with chemo and/or radiation in many different protocols.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar jesusbmine (20.57) Submitted: 11/27/2010 6:15:48 PM : Outperform Start Price: $5.99 ENMD Score: -73.49

yes

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar denaliguy (< 20) Submitted: 10/18/2010 4:19:43 PM : Outperform Start Price: $3.79 ENMD Score: -51.13

Watch for thid in China

Report this Post Add Comment | Reply | Permalink
View All 15 Pitches »

Leaderboard

Find the members with the highest scoring picks in ENMD.

Score Leader

TinyCapsWatch

TinyCapsWatch (98.48) Score: +101.41

The Score Leader is the player with the highest score across all their picks in ENMD.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
hlacheen 98.88 12/22/2006 Underperform 5Y $18.59 -86.87% +1.43% +88.31 1 Comment
Jroberts4 < 20 12/14/2006 Underperform 3Y $18.59 -86.87% +1.28% +88.15 0 Comment
sorilli < 20 1/3/2007 Underperform 3Y $17.71 -86.22% +1.00% +87.22 0 Comment
goofy4200 98.05 12/13/2006 Underperform NS $17.82 -86.31% +0.80% +87.11 0 Comment
jilbear 34.41 4/11/2007 Underperform NS $19.58 -87.54% -0.56% +86.98 1 Comment
MassProduced 95.67 2/20/2007 Underperform NS $17.93 -86.39% -1.30% +85.10 0 Comment
timedata 82.51 6/1/2007 Underperform NS $21.67 -88.74% -7.01% +81.73 0 Comment
EXOTHERMIC 84.80 6/1/2007 Underperform 5Y $21.56 -88.68% -6.98% +81.71 0 Comment
GoodOmens 94.28 6/1/2007 Underperform 3M $21.01 -88.39% -6.84% +81.54 0 Comment
amteague777 95.85 6/4/2007 Underperform 5Y $20.90 -88.33% -6.80% +81.53 2 Comments
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ENMD.

Featured Broker Partners